Switch theme
Sign up to access all valuation multiples
Adocia is a clinical-stage biotechnology company. It specializes in the development of formulations of already approved therapeutic proteins and peptides for the treatment of diabetes and other metabolic diseases. The firm has developed Biochaperone, a proprietary technology platform to enhance the effectiveness of therapeutic proteins. The company's clinical pipeline includes Biochaperone Lispro, Biochaparone Combo, Biochaparone Glucagon, and others. Its pre-clinical pipeline includes BioChaperone LisPram, BioChaperone Glargine GLP-1, and BioChaperone Glucagon GLP1. Its patent portfolio mainly consists of chronic wound healing, insulin therapy, and monoclonal antibodies.
2005
104
LTM Revenue $10.0M
LTM EBITDA n/a
$74.2M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Adocia has a last 12-month revenue of $10.0M and a last 12-month EBITDA of n/a.
In the most recent fiscal year, Adocia achieved revenue of $2.3M and an EBITDA of -$20.8M.
Adocia expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Adocia valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $2.3M | $10.0M | XXX | XXX | XXX |
| Gross Profit | $0.2M | $10.3M | XXX | XXX | XXX |
| Gross Margin | 8% | 103% | XXX | XXX | XXX |
| EBITDA | -$20.8M | n/a | XXX | XXX | XXX |
| EBITDA Margin | -900% | NaN% | XXX | XXX | XXX |
| Net Profit | -$24.4M | -$7.4M | XXX | XXX | XXX |
| Net Margin | -1058% | -74% | XXX | XXX | XXX |
| Net Debt | $18.9M | $14.4M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Adocia's stock price is EUR 4 (or $4).
Adocia has current market cap of EUR 66.2M (or $71.1M), and EV of EUR 69.1M (or $74.2M).
See Adocia trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $74.2M | $71.1M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Adocia has market cap of $71.1M and EV of $74.2M.
Adocia's trades at 7.4x LTM EV/Revenue multiple, and n/a LTM EBITDA.
Analysts estimate Adocia's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Adocia and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $74.2M | XXX | XXX | XXX |
| EV/Revenue | 7.4x | XXX | XXX | XXX |
| EV/EBITDA | n/a | XXX | XXX | XXX |
| P/E | n/a | XXX | XXX | XXX |
| P/E/Growth | n/a | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpAdocia's NTM/LTM revenue growth is -100%
Adocia's revenue per employee for the last fiscal year averaged $22K, while opex per employee averaged $0.2M for the same period.
Over next 12 months, Adocia's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Adocia's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Adocia and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 333% | XXX | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | XXX | XXX | XXX |
| EBITDA Growth | n/a | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | n/a | XXX | XXX | XXX | XXX |
| Revenue per Employee | $22K | XXX | XXX | XXX | XXX |
| Opex per Employee | $0.2M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| Opex to Revenue | 727% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Julphar | XXX | XXX | XXX | XXX | XXX | XXX |
| Galapagos | XXX | XXX | XXX | XXX | XXX | XXX |
| Pharming | XXX | XXX | XXX | XXX | XXX | XXX |
| Vivoryon Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| Armata Pharmaceuticals | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Adocia acquired XXX companies to date.
Last acquisition by Adocia was XXXXXXXX, XXXXX XXXXX XXXXXX . Adocia acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Adocia founded? | Adocia was founded in 2005. |
| Where is Adocia headquartered? | Adocia is headquartered in France. |
| How many employees does Adocia have? | As of today, Adocia has 104 employees. |
| Is Adocia publicy listed? | Yes, Adocia is a public company listed on PAR. |
| What is the stock symbol of Adocia? | Adocia trades under ADOC ticker. |
| When did Adocia go public? | Adocia went public in 2012. |
| Who are competitors of Adocia? | Similar companies to Adocia include e.g. Julphar, Galapagos, Pharming, Vivoryon Therapeutics. |
| What is the current market cap of Adocia? | Adocia's current market cap is $71.1M |
| What is the current revenue of Adocia? | Adocia's last 12-month revenue is $10.0M. |
| What is the current EV/Revenue multiple of Adocia? | Current revenue multiple of Adocia is 7.4x. |
| What is the current revenue growth of Adocia? | Adocia revenue growth between 2023 and 2024 was 333%. |
| Is Adocia profitable? | Yes, Adocia is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
